Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protective antibody to endotoxin core: the emperor's new clothes?

× No keyword cloud information.

15 in total

Review 1. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors: I G Mitov; D G Terziiski
Journal: Infection Date: 1991 Nov-Dec Impact factor: 3.553

Review 2. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.

Authors: J C Hurley
Journal: Drugs Date: 1994-06 Impact factor: 9.546

3. Intravenous immune globulin impairs anti-bacterial defences of a cyclophosphamide-treated host.

Authors: A S Cross; G Siegel; W R Byrne; M Trautmann; D S Finbloom
Journal: Clin Exp Immunol Date: 1989-05 Impact factor: 4.330

4. Biological therapy of sepsis.

Authors: J A Norton
Journal: Ann Surg Date: 1994-11 Impact factor: 12.969

5. Role of surface-exposed loops of Haemophilus influenzae protein P2 in the mitogen-activated protein kinase cascade.

Authors: Stefania Galdiero; Domenica Capasso; Mariateresa Vitiello; Marina D'Isanto; Carlo Pedone; Massimiliano Galdiero
Journal: Infect Immun Date: 2003-05 Impact factor: 3.441

6. Antibodies against core and O antigen epitopes of Escherichia coli O83 in rabbit antisera and in commercial human immunoglobulin.

Authors: F Orskov; I Orskov
Journal: Med Microbiol Immunol Date: 1991 Impact factor: 3.402

7. Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.

Authors: S A David; R Silverstein; C R Amura; T Kielian; D C Morrison
Journal: Antimicrob Agents Chemother Date: 1999-04 Impact factor: 5.191

8. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors: M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal: Infect Immun Date: 1993-08 Impact factor: 3.441

9. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.

Authors: S M Opal; A S Cross; J C Sadoff; H H Collins; N M Kelly; G H Victor; J E Palardy; M W Bodmer
Journal: J Clin Invest Date: 1991-09 Impact factor: 14.808

10. Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.

Authors: M Nys; P Damas; L Joassin; M Lamy
Journal: Ann Surg Date: 1993-03 Impact factor: 12.969